AMPIO PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.27 USD | -5.26% |
|
+20.00% | -86.83% |
| Apr. 15 | Ampio Pharmaceuticals, Inc.(NYSEAM:AMPE) dropped from S&P TMI Index | CI |
| Mar. 27 | Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Presentation Operator MessageOperator (Operator)Thank you, and welcome to Ampio Pharmaceutical...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Ampio Pharmaceuticals, Inc. is a drug discovery and development company. The Company is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.
| 1st Jan change | Capi. | |
|---|---|---|
| -86.83% | 324K | |
| +5.66% | 109B | |
| +11.23% | 105B | |
| -0.38% | 22.25B | |
| -12.15% | 22.09B | |
| -7.66% | 18.68B | |
| -36.52% | 17.58B | |
| -10.09% | 16.85B | |
| +3.33% | 13.76B | |
| +36.58% | 12.46B |
- Stock Market
- Equities
- AMPE Stock
- News Ampio Pharmaceuticals, Inc.
- Transcript : Ampio Pharmaceuticals, Inc. - Special Call
